Comparative Pharmacology
Head-to-head clinical analysis: DESLORATADINE AND PSEUDOEPHEDRINE SULFATE 24 HOUR versus EPI E Z PEN JR.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DESLORATADINE AND PSEUDOEPHEDRINE SULFATE 24 HOUR versus EPI E Z PEN JR.
DESLORATADINE AND PSEUDOEPHEDRINE SULFATE 24 HOUR vs EPI E Z PEN JR
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Desloratadine is a long-acting tricyclic histamine antagonist with selective H1-receptor histamine antagonist activity. Pseudoephedrine sulfate is an alpha-adrenergic receptor agonist causing vasoconstriction.
Epinephrine is a direct-acting sympathomimetic amine that acts on alpha- and beta-adrenergic receptors. Alpha receptor activation increases peripheral vascular resistance and reverses hypotension, while beta receptor activation causes bronchodilation, increased heart rate, and myocardial contractility.
One tablet (desloratadine 5 mg/pseudoephedrine sulfate 240 mg) orally once daily.
Epinephrine 0.3 mg (0.3 mL of 1:1000 solution) intramuscularly into the anterolateral thigh, repeated every 5-15 minutes as necessary for anaphylaxis.
None Documented
None Documented
Desloratadine: 27 hours (terminal); pseudoephedrine sulfate: 5-8 hours (terminal, dependent on urine pH).
Short terminal half-life of approximately 2-3 minutes; requires continuous infusion for sustained effect due to rapid uptake and metabolism.
Desloratadine: 41% urine (metabolites), 47% feces (metabolites); pseudoephedrine sulfate: 70-90% renal (unchanged), 1% biliary.
Primarily renal: epinephrine is metabolized in the liver and tissues, with metabolites (metanephrine, vanillylmandelic acid) excreted in urine; <5% excreted unchanged.
Category A/B
Category C
Sympathomimetic
Sympathomimetic